Wegener's granulomatosis (WG) is;currently categorized as one of the antine
utrophil cytoplasmic antibody (ANCA)associated small-vessel vasculitides di
stinguished by its predilection to affect the upper and lower respiratory t
racts and kidneys clinically and histologically by the presence of necrosis
, granulomatous inflammation, and vasculitis. However, small biopsies, espe
cially from the head and neck region, often lack all these diagnostic histo
logic findings. Other common histologic features of WG include microabscess
es and scattered multinucleated giant cells in a highly inflammatory backgr
ound. Support from distinctive clinical setting or positive cytoplasmic (C)
-ANCA testing may help establish the diagnosis of WG in cases lacking all t
he typical pathologic findings. The histopathologic differential diagnosis
of WG includes nonspecific inflammatory conditions, infections, angiocentri
c lymphomas, collagen vascular diseases, and other forms of angiitis and gr
anulomatosis. The prognosis of WG has dramatically improved from the 18% 5-
month survival rate before the era of immunosuppressive therapy to the curr
ent remission rate of over 75% with a regimen of cyclophosphamide and gluco
corticoids. A significant rate of relapse and profound disease- and/or trea
tment-related morbidity still occur. The cause of WG remains unknown, but c
ircumstantial evidences;suggest the potential roles of ANCA and infection i
n the pathogenesis. Copyright (C) 2001 by W.B. Saunders Company.